T Cell Activation and Proinflammatory Cytokine Production in Clinically Cured Tuberculosis Are Time-Dependent and Accompanied by Upregulation of IL-10

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  da Silva, Marcos Vinícius ^a   Figueiredo, Amanda A ^a   Machado, Juliana R ^a   Castellano, Lúcio C ^b   Alexandre, Patricia B D ^d   Oliveira, Rafael F ^a   Faria, Gladstone E L ^a   Pereira, Sanívia A L ^c   Rodrigues, Denise B R ^c   Rodrigues, Virmondes ^a  

^a Triângulo Mineiro Federal University   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c UNIVERSITY OF UBERABA   (Brazil)

^d Uberaba Municipal Department of Health   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; THORAX RADIOGRAPHY; UPREGULATION; BLOOD; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE; TIME FACTOR; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES; TIME FACTORS; TUBERCULOSIS; UP-REGULATION;

EID: 84879151683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065492     Document Type: Article

References (72)

1. WHO (2010) WHO global tuberculosis control report 2010. Summary. Cent Eur J Public Health 18: 237.
2. Flynn JL, Chan J, (2001) Immunology of tuberculosis. Annu Rev Immunol 19: 93-129.
3. Denis M, (1991) Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 132: 150-157.
4. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, et al. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766.
5. Jacobs M, Brown N, Allie N, Ryffel B, (2000) Fatal Mycobacterium bovis BCG infection in TNF-LT-alpha-deficient mice. Clin Immunol 94: 192-199.
6. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098-1104.
7. Howard AD, Zwilling BS, (1999) Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clin Exp Immunol 115: 428-434.
8. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF, (1996) Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun 64: 1351-1356.
9. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA, (1997) T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158: 315-321.
10. Higgins DM, Sanchez-Campillo J, Rosas-Taraco AG, Lee EJ, Orme IM, et al. (2009) Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis (Edinb) 89: 149-157.
11. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. (2007) Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
12. BRASIL (2013) TUBERCULOSIS- Confirmed cases reported in the Information System for Notifiable Diseases- Sinan Net- Brazil- Confirmed by Diagnostic Year and Munic. notification. Brazilian Ministry of Health Available: http://dtr2004.saude.gov.br/sinanweb/.
13. Spindola De Miranda S, Campos De Oliveira A, Xavier Santos A, Pereira Prado D, Leao Soares C, et al. (2012) Positive tuberculin test and risk of infection by Mycobacterium tuberculosis in a tuberculosis clinic settled in an upright building, in Minas Gerais, Brazil. Rev Med Chil 140: 1022-1027.
14. Ziegler SF, Ramsdell F, Alderson MR, (1994) The activation antigen CD69. Stem Cells 12: 456-465.
15. Testi R, Phillips JH, Lanier LL, (1989) T cell activation via Leu-23 (CD69). J Immunol 143: 1123-1128.
16. Hara T, Jung LK, Bjorndahl JM, Fu SM, (1986) Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. J Exp Med 164: 1988-2005.
17. Maino VC, Suni MA, Ruitenberg JJ, (1995) Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 20: 127-133.
18. Avgustin B, Kotnik V, Skoberne M, Malovrh T, Skralovnik-Stern A, et al. (2005) CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens. Clin Diagn Lab Immunol 12: 101-106.
19. Li L, Qiao D, Fu X, Lao S, Zhang X, et al. (2011) Identification of M. tuberculosis-specific Th1 cells expressing CD69 generated in vivo in pleural fluid cells from patients with tuberculous pleurisy. PLoS One 6: e23700.
20. Kruisbeek AM, Shevach E, Thornton AM, (2004) Proliferative assays for T cell function. Curr Protoc Immunol Chapter 3: Unit 3 12.
21. Lee JS, Song CH, Kim CH, Kong SJ, Shon MH, et al. (2002) Profiles of IFN-gamma and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis. Clin Exp Immunol 128: 516-524.
22. Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P, (2003) Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 38: 249-256.
23. Ribeiro-Rodrigues R, Resende Co T, Rojas R, Toossi Z, Dietze R, et al. (2006) A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol 144: 25-34.
24. Bold TD, Banaei N, Wolf AJ, Ernst JD, (2011) Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo. PLoS Pathog 7: e1002063.
25. Bold TD, Ernst JD, (2012) CD4+ T cell-dependent IFN-gamma production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol 189: 2530-2536.
26. Ottenhoff TH, Kumararatne D, Casanova JL, (1998) Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 19: 491-494.
27. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondaneche MC, et al. (1999) A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 21: 370-378.
28. Casanova JL, (2001) Mendelian susceptibility to mycobacterial infection in man. Swiss Med Wkly 131: 445-454.
29. Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, et al. (2007) Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 75: 820-829.
30. Nandi B, Behar SM, (2011) Regulation of neutrophils by interferon-gamma limits lung inflammation during tuberculosis infection. J Exp Med 208: 2251-2262.
31. Smith SM, Klein MR, Malin AS, Sillah J, McAdam KP, et al. (2002) Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis (Edinb) 82: 7-13.
32. Sharma S, Sharma M, Roy S, Kumar P, Bose M, (2004) Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis. Immunol Cell Biol 82: 377-382.
33. Vankayalapati R, Wizel B, Weis SE, Klucar P, Shams H, et al. (2003) Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis. Clin Infect Dis 36: 24-28.
34. Pereira CB, Palaci M, Leite OH, Duarte AJ, Benard G, (2004) Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations. Microbes Infect 6: 25-33.
35. Feng CG, Jankovic D, Kullberg M, Cheever A, Scanga CA, et al. (2005) Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production. J Immunol 174: 4185-4192.
36. Roach DR, Briscoe H, Saunders B, France MP, Riminton S, et al. (2001) Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection. J Exp Med 193: 239-246.
37. Bean AG, Roach DR, Briscoe H, France MP, Korner H, et al. (1999) Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162: 3504-3511.
38. Bopst M, Garcia I, Guler R, Olleros ML, Rulicke T, et al. (2001) Differential effects of TNF and LTalpha in the host defense against M. bovis BCG. Eur J Immunol 31: 1935-1943.
39. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, et al. (1995) T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 63: 3231-3234.
40. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, et al. (1999) Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180: 2069-2073.
41. Castellano LR, Filho DC, Argiro L, Dessein H, Prata A, et al. (2009) Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. Hum Immunol 70: 383-390.
42. Caldas A, Favali C, Aquino D, Vinhas V, van Weyenbergh J, et al. (2005) Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis 5: 113.
43. Jason J, Archibald LK, Nwanyanwu OC, Byrd MG, Kazembe PN, et al. (2001) Comparison of serum and cell-specific cytokines in humans. Clin Diagn Lab Immunol 8: 1097-1103.
44. Walker D, Jason J, Wallace K, Slaughter J, Whatley V, et al. (2002) Spontaneous cytokine production and its effect on induced production. Clin Diagn Lab Immunol 9: 1049-1056.
45. Petit-Bertron AF, Fitting C, Cavaillon JM, Adib-Conquy M, (2003) Adherence influences monocyte responsiveness to interleukin-10. J Leukoc Biol 73: 145-154.
46. O'Garra A, Vieira P, (2007) T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 7: 425-428.
47. Hunter CA, Ellis-Neyes LA, Slifer T, Kanaly S, Grunig G, et al. (1997) IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 158: 3311-3316.
48. Deckert M, Soltek S, Geginat G, Lutjen S, Montesinos-Rongen M, et al. (2001) Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect Immun 69: 4561-4571.
49. Sun J, Madan R, Karp CL, Braciale TJ, (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15: 277-284.
50. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, et al. (1996) In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 157: 798-805.
51. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, et al. (2000) IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 164: 5375-5382.
52. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y, (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203: 777-788.
53. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL, (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
54. Herrero C, Hu X, Li WP, Samuels S, Sharif MN, et al. (2003) Reprogramming of IL-10 activity and signaling by IFN-gamma. J Immunol 171: 5034-5041.
55. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Lugos MD, et al. (2006) Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia. PLoS One 1: e68.
56. Sakaguchi S, (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
57. Endharti AT, Rifa IM, Shi Z, Fukuoka Y, Nakahara Y, et al. (2005) Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175: 7093-7097.
58. Zhu J, Yamane H, Paul WE, (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489.
59. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, et al. (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8: 1390-1397.
60. Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, et al. (2008) IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9: 1347-1355.
61. Capo C, Zaffran Y, Zugun F, Houpikian P, Raoult D, et al. (1996) Production of interleukin-10 and transforming growth factor beta by peripheral blood mononuclear cells in Q fever endocarditis. Infect Immun 64: 4143-4147.
62. Esnault S, Benbernou N, Lavaud F, Shin HC, Potron G, et al. (1996) Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin Exp Immunol 103: 111-118.
63. Baker KS, Roncarolo MG, Peters C, Bigler M, DeFor T, et al. (1999) High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths. Bone Marrow Transplant 23: 1123-1129.
64. Jason J, Buchanan I, Archibald LK, Nwanyanwu OC, Bell M, et al. (2000) Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections. J Infect Dis 182: 474-481.
65. Bhattacharyya S, Singla R, Dey AB, Prasad HK, (1999) Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun 67: 5597-5603.
66. Tapaninen P, Korhonen A, Pusa L, Seppala I, Tuuminen T, (2010) Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence? Int J Tuberc Lung Dis 14: 347-355.
67. Woodland DL, Kohlmeier JE, (2009) Migration, maintenance and recall of memory T cells in peripheral tissues. Nat Rev Immunol 9: 153-161.
68. North RJ, (1998) Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 113: 55-58.
69. Schmid D, Munz C, (2007) Innate and adaptive immunity through autophagy. Immunity 27: 11-21.
70. Harris J, Master SS, De Haro SA, Delgado M, Roberts EA, et al. (2009) Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages. Vet Immunol Immunopathol 128: 37-43.
71. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
72. Jurado JO, Pasquinelli V, Alvarez IB, Pena D, Rovetta AI, et al. (2012) IL-17 and IFN-gamma expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J Leukoc Biol 91: 991-1002.